Funds › Clark Estates Inc
Clark Estates Inc
13F for Q3 2026, filed Nov 10, 2026. 89 positions worth $430.4M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Latest report
Q3 2026
filed Nov 10, 2026
Reported value
$430.4M
−$3.3M (0.8%) vs Q2 2026
Positions
89
90 in Q2 2026
Top 10 share
53.7%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Clark Estates Inc in the latest 13F quarter?
Using 13F.ai, how has Clark Estates Inc's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Clark Estates Inc's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | Ea Series Trust Eucl Fun Val Etf | 1.59M | $62.3M | 14.5% | -7.9% | 13F ↗ |
| 2 | Vanguard Tax-Managed Fds | 375,215 | $26.5M | 6.2% | +1.1% | 13F ↗ |
| 3 | DIS Walt Disney Company | 200,000 | $21.0M | 4.9% | Unchanged | 13F ↗ |
| 4 | UL Unilever PLC · ADR | 335,000 | $20.3M | 4.7% | -9.5% | 13F ↗ |
| 5 | WMG Warner Music Group Corp. | 705,000 | $19.5M | 4.5% | +31.8% | 13F ↗ |
| 6 | GEHC GE HealthCare Technologies Inc. | 265,000 | $17.3M | 4.0% | New | 13F ↗ |
| 7 | DG Dollar General Corporation | 142,500 | $17.0M | 4.0% | New | 13F ↗ |
| 8 | OTIS Otis Worldwide Corporation | 260,000 | $16.7M | 3.9% | New | 13F ↗ |
| 9 | HLN Haleon plc · ADR | 1.70M | $15.3M | 3.6% | Unchanged | 13F ↗ |
| 10 | BLCO Bausch + Lomb Corporation | 881,000 | $15.0M | 3.5% | Unchanged | 13F ↗ |
| 11 | SOLV Solventum Corporation | 160,000 | $14.1M | 3.3% | -20.0% | 13F ↗ |
| 12 | STTK Shattuck Labs, Inc. | 1.42M | $9.7M | 2.2% | -1.0% | 13F ↗ |
| 13 | HSIC Henry Schein, Inc. | 75,000 | $6.3M | 1.5% | -44.4% | 13F ↗ |
| 14 | DDD 3D Systems Corporation | 1.42M | $5.1M | 1.2% | Unchanged | 13F ↗ |
| 15 | MD Pediatrix Medical Group, Inc. | 153,000 | $3.9M | 0.9% | Unchanged | 13F ↗ |
| 16 | WLY John Wiley & Sons, Inc. | 81,200 | $3.9M | 0.9% | -14.0% | 13F ↗ |
| 17 | BBY Best Buy Co., Inc. | 43,700 | $3.9M | 0.9% | Unchanged | 13F ↗ |
| 18 | WEX WEX Inc. | 21,800 | $3.7M | 0.9% | Unchanged | 13F ↗ |
| 19 | RTO Rentokil Initial plc · ADR | 185,000 | $3.7M | 0.8% | New | 13F ↗ |
| 20 | CROX Crocs, Inc. | 28,900 | $3.4M | 0.8% | Unchanged | 13F ↗ |
| 21 | CTSH Cognizant Technology Solutions Corporation | 57,300 | $3.3M | 0.8% | Unchanged | 13F ↗ |
| 22 | STRA Strategic Education, Inc. | 42,300 | $3.3M | 0.8% | Unchanged | 13F ↗ |
| 23 | TNET TriNet Group, Inc. | 52,500 | $3.3M | 0.8% | Unchanged | 13F ↗ |
| 24 | MO Altria Group, Inc. | 48,613 | $3.3M | 0.8% | Unchanged | 13F ↗ |
| 25 | HALO Halozyme Therapeutics, Inc. | 29,500 | $3.3M | 0.8% | -34.3% | 13F ↗ |
| 26 | HRMY Harmony Biosciences Holdings, Inc. | 81,300 | $3.2M | 0.7% | Unchanged | 13F ↗ |
| 27 | OSPN OneSpan Inc. | 177,000 | $3.2M | 0.7% | Unchanged | 13F ↗ |
| 28 | GILD Gilead Sciences, Inc. | 20,375 | $3.0M | 0.7% | -21.7% | 13F ↗ |
| 29 | MTCH Match Group, Inc. | 74,800 | $3.0M | 0.7% | Unchanged | 13F ↗ |
| 30 | ADBE Adobe Inc. | 12,390 | $3.0M | 0.7% | +10.7% | 13F ↗ |
| 31 | CRUS Cirrus Logic, Inc. | 24,000 | $2.9M | 0.7% | New | 13F ↗ |
| 32 | UHS Universal Health Services, Inc. | 16,350 | $2.8M | 0.7% | New | 13F ↗ |
| 33 | VTRS Viatris Inc. | 157,500 | $2.8M | 0.6% | -8.2% | 13F ↗ |
| 34 | ADMA ADMA Biologics Inc | 278,000 | $2.8M | 0.6% | New | 13F ↗ |
| 35 | FTDR Frontdoor, Inc. | 38,000 | $2.8M | 0.6% | Unchanged | 13F ↗ |
| 36 | PFE Pfizer, Inc. | 96,750 | $2.8M | 0.6% | Unchanged | 13F ↗ |
| 37 | LMB Limbach Holdings, Inc. | 56,300 | $2.8M | 0.6% | New | 13F ↗ |
| 38 | LOPE Grand Canyon Education, Inc. | 17,600 | $2.7M | 0.6% | New | 13F ↗ |
| 39 | OPCH Option Care Health, Inc. | 118,000 | $2.7M | 0.6% | Unchanged | 13F ↗ |
| 40 | KFY Korn Ferry | 36,800 | $2.6M | 0.6% | Unchanged | 13F ↗ |
| 41 | HLF Herbalife Ltd. | 217,000 | $2.6M | 0.6% | New | 13F ↗ |
| 42 | EXPE Expedia Group, Inc. | 9,900 | $2.6M | 0.6% | -10.0% | 13F ↗ |
| 43 | AOS A.O. Smith Corporation | 46,000 | $2.6M | 0.6% | Unchanged | 13F ↗ |
| 44 | BLKB Blackbaud, Inc. | 61,900 | $2.6M | 0.6% | Unchanged | 13F ↗ |
| 45 | DORM Dorman Products, Inc. | 21,000 | $2.6M | 0.6% | Unchanged | 13F ↗ |
| 46 | TDC Teradata Corporation | 87,600 | $2.5M | 0.6% | Unchanged | 13F ↗ |
| 47 | ADT ADT Inc. | 412,000 | $2.5M | 0.6% | New | 13F ↗ |
| 48 | ZTS Zoetis Inc. | 35,650 | $2.5M | 0.6% | New | 13F ↗ |
| 49 | DOX Amdocs Limited | 42,800 | $2.4M | 0.6% | Unchanged | 13F ↗ |
| 50 | CLAR Clarus Corporation | 718,000 | $2.4M | 0.6% | +8.8% | 13F ↗ |
Showing the top 50 of 89 positions. Premium lists every position, plus puts and calls.
Changes since Q2 2026
16 new, 5 added to, 10 trimmed, 17 exited, 58 unchanged. By estimated dollars.
New positions (16)
| GEHC GE HealthCare Technologies Inc. | 265,000 | New | $17.3M |
| DG Dollar General Corporation | 142,500 | New | $17.0M |
| OTIS Otis Worldwide Corporation | 260,000 | New | $16.7M |
| RTO Rentokil Initial plc · ADR | 185,000 | New | $3.7M |
| CRUS Cirrus Logic, Inc. | 24,000 | New | $2.9M |
| UHS Universal Health Services, Inc. | 16,350 | New | $2.8M |
| ADMA ADMA Biologics Inc | 278,000 | New | $2.8M |
| LMB Limbach Holdings, Inc. | 56,300 | New | $2.8M |
| LOPE Grand Canyon Education, Inc. | 17,600 | New | $2.7M |
| HLF Herbalife Ltd. | 217,000 | New | $2.6M |
Added to (5)
Trimmed (10)
| Ea Series Trust Eucl Fun Val Etf | 1.59M | -7.9% | -$5.3M |
| HSIC Henry Schein, Inc. | 75,000 | -44.4% | -$5.0M |
| SOLV Solventum Corporation | 160,000 | -20.0% | -$3.5M |
| UL Unilever PLC · ADR | 335,000 | -9.5% | -$2.1M |
| HALO Halozyme Therapeutics, Inc. | 29,500 | -34.3% | -$1.7M |
| GILD Gilead Sciences, Inc. | 20,375 | -21.7% | -$841.7K |
| WLY John Wiley & Sons, Inc. | 81,200 | -14.0% | -$630.4K |
| EXPE Expedia Group, Inc. | 9,900 | -10.0% | -$289.7K |
| VTRS Viatris Inc. | 157,500 | -8.2% | -$249.2K |
| STTK Shattuck Labs, Inc. | 1.42M | -1.0% | -$93.6K |
Exited (17)
| AMRZ Amrize Ltd | 325,000 | Exited | -$17.3M |
| SONY Sony Group Corporation | 825,000 | Exited | -$16.5M |
| IQV IQVIA Holdings, Inc. | 52,185 | Exited | -$10.1M |
| MDT Medtronic plc. | 90,000 | Exited | -$7.0M |
| SNN Smith & Nephew SNATS, Inc. · ADR | 143,500 | Exited | -$4.1M |
| INDV Supernus, Inc. | 92,300 | Exited | -$3.8M |
| Catalyst Pharmaceuticals Inc | 113,918 | Exited | -$3.6M |
| BIIB Biogen Inc. | 15,300 | Exited | -$3.3M |
| ZD Ziff Davis, Inc. | 62,425 | Exited | -$3.3M |
| WKC World Kinect Corporation | 91,600 | Exited | -$3.0M |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Every position, puts and calls. Part of Premium.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Any two quarters side by side. Part of Premium.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 10, 2026 | 13F-HR | 89 | $430.4M | Current | SEC ↗ |
| Q2 2026 | Aug 5, 2026 | 13F-HR | 90 | $433.7M | Current | SEC ↗ |
| Q1 2026 | May 11, 2026 | 13F-HR | 97 | $416.2M | Current | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | 13F-HR | 98 | $412.1M | Current | SEC ↗ |
| Q3 2025 | Nov 10, 2025 | 13F-HR | 99 | $437.7M | Current | SEC ↗ |
| Q2 2025 | Aug 11, 2025 | 13F-HR | 97 | $445.7M | Current | SEC ↗ |
| Q1 2025 | May 8, 2025 | 13F-HR | 94 | $472.3M | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer